top of page

Aminoglycosides

Updated: May 25

Aminoglycosides are powerful antibiotics used in hospitals for serious infections. As a pharmacist, you'll often see them in IV forms, especially for critically ill patients. Understanding their pharmacology, administration, and toxicity risks is essential to support safe use.

General Principles of Link:

Medicine Link

What Are Aminoglycosides?

Aminoglycosides are concentration-dependent, bactericidal antibiotics that:

  • Inhibit bacterial protein synthesis by binding to the 30S ribosomal subunit

  • Cause cell membrane damage

  • Are effective mostly against aerobic Gram-negative bacteria, including Pseudomonas aeruginosa

📌 Examples:

  • IV/IM: Gentamicin, Amikacin, Streptomycin, Tobramycin

  • Oral (non-absorbed): Paromomycin – mainly used for intestinal infections


Core Medicines

1. Gentamicin


Gentamicin
Gentamicin

✅ Use:

  • Empiric therapy for serious Gram-negative infections (up to 48 hrs)

  • Pseudomonas aeruginosa, enterococcal endocarditis (with beta-lactam), brucellosis

  • Surgical prophylaxis

💊 Dose:

  • Once-daily IV/IM:

    • 60 mL/min CrCl: 5–7 mg/kg

    • 30–60 mL/min: 4–5 mg/kg

    • <30 mL/min: Specialist advice

  • Endocarditis: 1 mg/kg every 8 hrs (TDM required)

⚠️ Caution:

  • Renal/hearing impairment, elderly, neuromuscular disorders

  • Avoid in previous aminoglycoside ototoxicity

  • Use adjusted body weight if BMI >35

📋 Instructions:

  • Infuse IV over 15–30 minutes

  • Don’t mix with penicillins in same IV line — flush in between


2. Amikacin

Amikacin
Amikacin

✅ Use:

  • Resistant Gram-negative infections

  • Mycobacterial infections (e.g., TB, NTM)

💊 Dose:

  • 15–20 mg/kg IV/IM once daily

  • NTM: 10–15 mg/kg daily or 15–25 mg/kg 3x/week

  • Adjust based on renal function and therapeutic drug monitoring

⚠️ Caution:

  • Similar to gentamicin — especially in elderly, renal impairment, CF, burns, or ICU patients

  • Screen family history for mitochondrial mutations (A1555G) if history of aminoglycoside-induced deafness

📋 Instructions:

  • IV infusion over 15–30 mins or slow IV push (3–5 mins if <500 mg)


3. Tobramycin

Tobramycin
Tobramycin

✅ Use:

  • Gram-negative infections, P. aeruginosa, cystic fibrosis

  • Systemic use and inhaled formulations

💊 Dose:

  • IV: 5–7 mg/kg once daily

  • CrCl 30–60 mL/min: 4–5 mg/kg

  • CF: 10 mg/kg IV (max 660 mg), adjust via TDM

  • Inhaled: 300 mg twice daily for 28 days (cycle), or DPI 112 mg twice daily

⚠️ Caution:

  • Monitor renal function and serum levels

  • Inhaled use may cause cough, bronchospasm, or taste changes

  • Avoid mixing inhalation drug with other nebulised solutions

📋 Instructions:

  • Nebulised via PARI nebuliser over 15 minutes

  • Always administer bronchodilator first


Monitoring & Therapeutic Drug Levels

Situation

Monitoring Needed?

Notes

<48 hrs use

No (if stable renal function)

Empiric use only

>48 hrs use

Yes

TDM required

Method

AUC-based (preferred)

2 levels: 30 min & 6–14 hrs post-dose

Multiple doses/day

Trough level <1 mg/L

Especially for endocarditis

Renal Function

Daily creatinine if unstable

Or every 3–5 days if stable

AUC Target: Approx. 100 mg·h/L


⚠️ Side Effects

Effect

Description

Nephrotoxicity

Reversible. Risk ↑ with long treatment, dehydration, high dose

Ototoxicity

May be irreversible. Symptoms: tinnitus, hearing loss, vertigo

Neuromuscular blockade

Rare. Can cause respiratory depression. Reversed with IV calcium gluconate

Others (Rare)

Anaphylaxis, bronchospasm, peripheral neuropathy

👂 If hearing or balance symptoms occur, stop drug and refer.


Practice Points

  • Use empirically only for ≤48 hours → then de-escalate based on culture

  • Always check baseline renal function (CrCl) before starting

  • Hydration is key to reduce nephrotoxicity risk

  • Monitor for:

    • Vestibular symptoms: nausea, gait disturbance

    • Cochlear symptoms: hearing loss, tinnitus

  • If renal function worsens early (<5 days), it’s often the illness—not yet drug toxicity


Counselling Points

Here’s how you can explain it to patients on longer courses:

“This antibiotic is strong and effective, but may sometimes affect your kidneys or hearing. Please let your doctor know if you feel dizzy, notice ringing in your ears, or have any hearing changes. You’ll likely have regular blood tests during treatment.”

For inhaled tobramycin:

“Use your reliever inhaler first, then wait 15 minutes before using this nebuliser. Rinse your mouth afterward and watch for hoarseness or cough.”

Lifestyle Tips for Patients

Tip

Reason

Stay well hydrated

Prevents nephrotoxicity

Report hearing/balance issues early

May indicate early ototoxicity

Take care with balance if dizzy

Reduce fall risk from vestibular effects

Attend all blood tests

To monitor drug levels and kidney function

Use bronchodilator before inhaled tobramycin

Reduces bronchospasm risk


✅ Summary for Pharmacists

Key Point

Takeaway

Main use

Serious Gram-negative infections (IV only)

Preferred dosing

Once daily (unless endocarditis)

Monitoring

TDM if >48 hrs or impaired renal function

Toxicity signs

Hearing changes, dizziness, rising creatinine

Practical tip

Use ideal/adjusted weight for dosing; don’t mix with penicillins


Auxe Pharma

Quick Links

Home

For Employers

For Pharmacists

Training Program

Contact Us

+61 (2) 1234 5678

Sydney, Australia

Copyright © 2025 AUXE Pharma

Connecting talented pharmacists with Australian healthcare opportunities.

Our Services

Pharmacy Recruitment

Pharmacist Training

Visa Assistance

Career Support

Relocation Services

bottom of page